Competitive Intelligence (CI) plays a crucial role in the hematology domain, where rapid advancements in treatments, therapies, and diagnostics are prevalent. With an increasing focus on blood disorders such as polycythemia vera, leukemia, hemophilia, and sickle cell disease, CI helps pharmaceutical companies, healthcare providers, and research organizations navigate this complex and competitive landscape.
Comments
0 comment